Breaking News
Sort by:
Top Post
Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First mRNA COVID-19 Vaccines in Ghana
Zipline, the global leader in instant logistics, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced […]
MyLife Technologies Raises US$4.0 Million to Further Develop its Vaccine Delivery Technology Through Painless Ceramic Vaccine Patches for 'Pandemic Preparedness'
MyLife Technologies, a Dutch vaccine and drug delivery company, focusing on the development of ceramic […]
Booster Bookings Boom As One Million Book Life-Saving Jab in Three Days
More than one million booster jabs have been booked in the last three days as […]
CN Bio and iiCON Announce COVID-19 Research Collaboration
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological […]
New Phase 3 Analyses Show That a Single Dose of REGEN-COV® (casirivimab and imdevimab) Provides Long-term Protection Against COVID-19
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced additional positive results from a Phase 3 trial jointly run with the […]
Leader in COVID Testing Launches Compliance Solution to Help Employers Meet OSHA Mandate
Vault Health, Inc. today announced the release of its COVID Compliance Solution, a new turnkey product […]
Merck and Ridgeback’s Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics […]
First Oral Antiviral for COVID-19, Lagevrio (molnupiravir), Approved by MHRA
The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and […]
LumiraDx Announces the Intended Use for its FDA EUA Authorized High Sensitivity COVID-19 Antigen Test has been Expanded to Include Testing of Asymptomatic Individuals
Today, LumiraDx (Nasdaq: LMDX) a next-generation point of care (POC) diagnostics company announced that the intended use for its Food […]
Walk-in Sites Open Up For People To Get Covid-19 Booster Jab
Hundreds of walk-in sites across the country are now offering booster vaccines as the NHS […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more